We are excited to share a historic milestone from portfolio company Conceivable Life Sciences: the birth of the world’s first IVF baby conceived through a fully automated, remotely controlled, and AI-powered ICSI procedure.

‍

Using their proprietary platform, Conceivable’s researchers — some operating from over 3,700 kilometers away — successfully performed automated intracytoplasmic sperm injection (ICSI), one of the most delicate and critical steps in IVF. Remarkably, the system executed all 23 steps of ICSI autonomously and achieved 80% fertilization success, a rate on par with traditional manual methods.

‍

One of the resulting embryos was transferred to a 40-year-old patient, who carried a healthy baby boy to term without complications.

‍

This clinical breakthrough, recently published in Reproductive BioMedicine Online and featured in global media, validates a core component of Conceivable’s fully automated and AI-powered embryology platform, AURA. It marks a turning point in the application of AI, robotics, and automation in fertility care — demonstrating the potential to expand access, improve scalability, and lower the cost of IVF for millions of aspiring parents worldwide.

‍

We are proud to back Conceivable on this journey and look forward to their continued progress as they continue to evaluate their fully automated lab, broaden clinical access, and prepare for global expansion.